A cabazitaxel liposome for increased solubility, enhanced antitumor effect and reduced systemic toxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A cabazitaxel liposome for increased solubility, enhanced antitumor effect and reduced systemic toxicity

Published:2019-11 Issue:6 Volume:14 Page:658-667
ISSN:1818-0876
Container-title:Asian Journal of Pharmaceutical Sciences
language:en
Short-container-title:Asian Journal of Pharmaceutical Sciences

Author:

Yin Xiaoyi,Luo Lihua,Li Wei,Yang Jie,Zhu Chunqi,Jiang Mengshi,qin Bing,Yuan Xiaoling,Yin Hang,Lu Yichao,Du Yongzhong,Chen Dawei,You Jian

Funder

National Key R&D Program of China

Natural Science Foundation of China

Basic Public Welfare Research Project of Zhejiang Province, China

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference22 articles.

1. Alternative drug formulations of docetaxel: a review;Frederike;Anti Cancer Drugs,2007

2. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions;Esther;Ann Allergy Asthma Immunol,2005

3. Nanocarriers as an emerging platform for cancer therapy;Dan;Nat Nanotech,2007

4. Controlled drug release from pharmaceutical nanocarriers;Jinhyun;Chem Eng Sci,2015

5. A personal experience for formulating poorly water soluble drugs;Nanoparticles;J Control Release,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-step emulsification for the fabrication of homogeneous PCL microspheres encapsulating geniposidic acid with antioxidant properties;Particuology;2024-09

2. A Review of the Efficacy of Nanomaterial-Based Natural Photosensitizers to Overcome Multidrug Resistance in Cancer;Pharmaceutics;2024-08-24

3. Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model;International Journal of Pharmaceutics;2024-08

4. A novel cabazitaxel liposomes modified with ginsenoside Rk1 for cancer targeted therapy;Acupuncture and Herbal Medicine;2024-02-02

5. Exploration of Solubilization Strategies: Enhancing Bioavailability for Low Solubility Drugs;International Journal of Newgen Research in Pharmacy & Healthcare;2023-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3